Definium Therapeutics Inc (DFTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Operating Expenses | 166,309 | 103,916 | 93,866 | 66,331 | 93,854 |
| Operating Income | -166,309 | -103,916 | -93,866 | -66,331 | -93,854 |
| Interest Expense | 5,482 | 2,283 | 920 | 0 | 0 |
| Other Income | -12,002 | -2,480 | -946 | 9,535 | -339 |
| Pre-tax Income | -183,793 | -108,679 | -95,732 | -56,796 | -94,193 |
| Income Tax | N/A | N/A | N/A | N/A | -1,157 |
| Net Income Continuous | -183,793 | -108,679 | -95,732 | -56,796 | -93,036 |
| Net Income | $-183,793 | $-108,679 | $-95,732 | $-56,796 | $-93,036 |
| EPS Basic Total Ops | -2.06 | -1.54 | -2.44 | -1.84 | -3.40 |
| EPS Basic Continuous Ops | -2.06 | -1.54 | -2.44 | -1.84 | -3.40 |
| EPS Diluted Total Ops | -2.06 | -1.54 | -2.44 | -1.84 | -3.40 |
| EPS Diluted Continuous Ops | -2.06 | -1.54 | -2.44 | -1.84 | -3.40 |
| EPS Diluted Before Non-Recurring Items | -1.80 | -1.40 | -2.44 | -2.09 | -3.45 |
| EBITDA(a) | $-168,130 | $-103,389 | $-90,603 | $-63,151 | $-91,238 |